Early research (Phase 1)Study completedNCT03951623
What this trial is testing
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
Who this might be right for
Immune Thrombocytopenia (ITP)
Hutchison Medipharma Limited 45